(Q40122801)
Statements
The rho-kinase inhibitors Y-27632 and fasudil act synergistically with imatinib to inhibit the expansion of ex vivo CD34(+) CML progenitor cells (English)
J Burthem
K Rees-Unwin
R Mottram
J Adams
scientific article published on 7 June 2007